{"organizations": [], "uuid": "3b4fddeb501e4de272d27dc49654a4436c3731bc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/01/18/business-wire-alexion-to-report-fourth-quarter-and-full-year-2017-results-on-thursday-february-8-2018.html", "country": "US", "domain_rank": 767, "title": "Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T18:00:00.000+02:00", "replies_count": 0, "uuid": "3b4fddeb501e4de272d27dc49654a4436c3731bc"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/01/18/business-wire-alexion-to-report-fourth-quarter-and-full-year-2017-results-on-thursday-february-8-2018.html", "ord_in_thread": 0, "title": "Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018", "locations": [], "entities": {"persons": [{"name": "catherine hu d", "sentiment": "none"}, {"name": "elena ridloff", "sentiment": "none"}], "locations": [{"name": "conn.", "sentiment": "none"}, {"name": "usa", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "alexion", "sentiment": "negative"}, {"name": "alexion pharmaceuticals, inc.", "sentiment": "neutral"}, {"name": "alexion pharmaceuticals, inc", "sentiment": "none"}, {"name": "company", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW HAVEN, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2017 on Thursday, February 8, 2018 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast on Thursday, February 8, 2018, at 10:00 a.m. Eastern Time (ET).\nTo participate in this conference call, dial 800-239-9838 (USA) or 323-794-2551 (International), passcode 7453141 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 7453141. The audio webcast can be accessed on the Investor page of http://ir.alexion.com .\n[ALXN-G]\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180118005444/en/\nAlexion Pharmaceuticals, Inc.\nInvestors\nElena Ridloff, CFA\nVice President, Investor Relations\n(475) 230-3601\nor\nCatherine Hu\nDirector, Investor Relations\n(475) 230-3599\nSource: Alexion Pharmaceuticals, Inc.", "external_links": ["http://www.businesswire.com/news/home/20180118005444/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fir.alexion.com&esheet=51745189&newsitemid=20180118005444&lan=en-US&anchor=http%3A%2F%2Fir.alexion.com&index=1&md5=d825b495d354b3c66801a2da2a3545b0"], "published": "2018-01-18T18:00:00.000+02:00", "crawled": "2018-01-18T20:11:17.000+02:00", "highlightTitle": ""}